Date Submitted: Tue, 12 Feb 2019 13:38:03 GMT

LAW 3006 v00 : International Right to Health

Last edit: Wed, 30 Jan 2019 20:05:10 GMT

Druthers submitted by: ag1709
LLM Adjunct
UserID Name Email
ag1709 Grover, Anand
LAW 3006 v00: International Right to Health
International Right to Health
SaSu 10:00am-6:00pm
October 12-13 and October 19-20
30 (LAWG: 20/LAWJ: 10)


Introductory course in public international law or human rights, introduction to public international law and/or introduction to human rights


A student will be permitted to drop a course that meets for the first time after the add/drop period, without a transcript notation, if a student submits a written request to the Office of the Registrar prior to the start of the second class meeting. Withdrawals are permitted up until the last class for this specific course.

Would you like to offer the Pass/Fail grading option?

Does this course qualify as a "simulation course"?

Is this course available to distance students?
Is this a mandatory Pass-Fail course?


Personal Information


Anand Grover is a designated Senior Advocate, practicing in the Supreme Court of India, the Director of the HIV/AIDS Unit of Lawyer’s Collective (India), and the former United Nations Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health (2008-2014). In his regular practice, Mr. Grover has argued several landmark cases in the field of public interest and human rights law, including mass eviction cases (Olga Tellis & Ors v. Bombay Municipal Council), environmental cases (the Bhopal Gas Disaster case), and LGBT rights (Naz Foundation case). Mr. Grover has also done innovative work in the field of patent law, opposing the grant of patents for essential life-saving drugs. He successfully argued the first constitutional challenge to Section 3(d) of the Patents Act, 1970 on behalf of the Cancer Patient Aid Association in Novartis v Union of India, the patent linkage case of Bayer v Union of India and successfully defended against a challenge to the compulsory license issued for the manufacture of an kidney-cancer drug in Bayer v. Natco. During his time as the UN Special Rapporteur he focused his reports to promote non-discrimination, empower vulnerable groups and ensure meaningful participation of affected communities.

Key: 7365